Universities worldwide are tightening spending in the wake of the financial markets’ downturn. In Japan, Keio University has reported $233 million in investment losses. In the US, financial losses at Yale and Harvard have forced the colleges to delay new buildings and new hires. The failure of Iceland’s banking industry has hit UK universities, including […]
The latest figures from IMS Health show that worldwide sales for generic drugs increased just 3.6% to $78 billion for the twelve months ending in September, compared to 11.4% growth for the same period last year. The decline is attributed to price competition. In the US, the world’s largest generics market, where generics make up […]
The FDA will continue to allow off-label use of the antibiotic cephalosporin in animals raised for food, including cows, chickens and pigs. In July, the FDA announced that it would crack down on the use of off-label antibiotics in animals used for food. The American Medical Association is among the groups critical of the overuse […]
The steel industry could be ripe for a new round of mergers and acquisitions. The $800 billion industry has already experienced a number of mega-mergers during the last 10 years. Steel prices have fallen 50% over the last four months, as have stock valuations, leaving many companies vulnerable to takeovers. Companies with substantial cash and […]
The International Cancer Genome Consortium (ICGC) has announced projects in eight countries involving 11 funding organizations to study the genomic changes in eight forms of cancer. Each projects is expected to cost $20 million. Source: ICGC
As analytical instrument makers and laboratory product companies face downturns in key market segments, such as chemicals, energy and metals, due to the global economic crisis, national stimulus plans may provide some relief. The variety of plans announced over the last three months provide state funding designed to increase spending through business loans, tax reform […]
The European Chemical Industry Council (Cefic) forecasts that chemical production by the EU27 countries will decline 0.3% in 2009, after rising 0.2% this year. In contrast, US chemical production is expected to decline 1.1% this year before increasing 0.5% in 2009. Excluding pharmaceuticals, EU27 and US chemical output are each forecasted to decline this year, […]
Unable to raise funding, a number of biotechnology companies could soon go out of business. Five US biotech firms have filed for bankruptcy in the last month alone. Burrill & Co. report that in the first nine months of 2008, the amount of money raised by biotech companies fell 54% to $9.7 billion. Financing for […]
Major analytical instrument and laboratory supply companies weathered the economic storm quite well in the calendar-year third quarter. Dionex, Thermo Fisher Scientific, Varian and Waters each noted some order delays due to economic conditions, but in general companies stated that business was unaffected. However, the downturn in equity and capital markets worsened in mid-September, the […]
According to a new study by Wood Mackenzie, of the 160 refining projects announced since 2005 and scheduled to be operational between the next two to seven years, only 30 are expected to be completed. Nearly all of the projects that are going ahead are funded by national oil companies and will provide 12 million […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
